rs121909835
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000440.3(PDE6A):c.2053G>A(p.Val685Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000062 ( 0 hom. )
Consequence
PDE6A
NM_000440.3 missense
NM_000440.3 missense
Scores
10
6
3
Clinical Significance
Conservation
PhyloP100: 7.54
Genes affected
PDE6A (HGNC:8785): (phosphodiesterase 6A) This gene encodes the cyclic-GMP (cGMP)-specific phosphodiesterase 6A alpha subunit, expressed in cells of the retinal rod outer segment. The phosphodiesterase 6 holoenzyme is a heterotrimer composed of an alpha, beta, and two gamma subunits. cGMP is an important regulator of rod cell membrane current, and its dynamic concentration is established by phosphodiesterase 6A cGMP hydrolysis and guanylate cyclase cGMP synthesis. The protein is a subunit of a key phototransduction enzyme and participates in processes of transmission and amplification of the visual signal. Mutations in this gene have been identified as one cause of autosomal recessive retinitis pigmentosa. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.875
PP5
Variant 5-149883511-C-T is Pathogenic according to our data. Variant chr5-149883511-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 29874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-149883511-C-T is described in Lovd as [Pathogenic]. Variant chr5-149883511-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE6A | NM_000440.3 | c.2053G>A | p.Val685Met | missense_variant | 17/22 | ENST00000255266.10 | NP_000431.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE6A | ENST00000255266.10 | c.2053G>A | p.Val685Met | missense_variant | 17/22 | 1 | NM_000440.3 | ENSP00000255266.5 | ||
PDE6A | ENST00000508173.5 | n.2237G>A | non_coding_transcript_exon_variant | 15/20 | 1 | |||||
PDE6A | ENST00000613228.1 | c.1810G>A | p.Val604Met | missense_variant | 15/20 | 5 | ENSP00000478060.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251012Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135688
GnomAD3 exomes
AF:
AC:
13
AN:
251012
Hom.:
AF XY:
AC XY:
6
AN XY:
135688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000623 AC: 91AN: 1460890Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 726868
GnomAD4 exome
AF:
AC:
91
AN:
1460890
Hom.:
Cov.:
30
AF XY:
AC XY:
41
AN XY:
726868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
GnomAD4 genome
AF:
AC:
10
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 25, 2023 | Published functional studies in mice demonstrate a damaging effect with increased accumulation of cGMP, increased PARP activity, and severe retinal degeneration (Sothilingam et al., 2015; Jiao et al., 2016); This variant is associated with the following publications: (PMID: 18849587, 32531858, 26188004, 27551530, 21039428, 28157543, 33851411, 31589614, 33576794, 32037395, 35533076, 32553897, 33945959, 37601102, 34795310, 31884596, 34557646, 36819107, 33057649) - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 685 of the PDE6A protein (p.Val685Met). This variant is present in population databases (rs121909835, gnomAD 0.009%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 21039428, 28157543). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 29874). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PDE6A protein function. Experimental studies have shown that this missense change affects PDE6A function (PMID: 18849587, 26188004, 27551530). For these reasons, this variant has been classified as Pathogenic. - |
Retinitis pigmentosa 43 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jan 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.
REVEL
Pathogenic
Sift
Uncertain
.;D;.
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;.
Vest4
MVP
MPC
0.46
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at